Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Imbalances in Cardiac Output01:26

Imbalances in Cardiac Output

1.8K
The heart's primary function is to pump blood throughout the body, maintaining a balance between blood sent out (cardiac output) and blood returning (venous return). If this balance is disrupted, it can result in congestive heart failure (CHF), a severe condition where the heart becomes an inefficient pump, leading to inadequate blood circulation.
CHF can occur due to the failure of either side of the heart. Left-side failure leads to pulmonary congestion—the right side continues to send...
1.8K
Heart Failure I: Introduction01:27

Heart Failure I: Introduction

183
Heart failure refers to a clinical syndrome caused by structural or functional cardiac disorders that prevent the heart from pumping an adequate amount of blood to meet the body's metabolic needs. This condition often arises from myocardial infarction or ischemia, leading to decreased cardiac output, reduced tissue perfusion, impaired gas exchange, fluid volume imbalance, and decreased functional ability.Heart failure can result from disruptions in the mechanisms that regulate cardiac output...
183
Pathophysiology of Heart Failure01:17

Pathophysiology of Heart Failure

2.1K
Heart failure (HF) is a progressive syndrome involving ventricles that leads to inadequate cardiac output. It can be classified based on location and output or ejection fraction. Ejection fraction (EF) is an essential measurement in the diagnosis and surveillance of HF. Reduced EF corresponds to systolic heart failure (HFrEF). However, HF with preserved ejection fraction (HFpEF) is becoming increasingly prevalent. Also known as diastolic HF, this form of HF is related to aging. The...
2.1K
Heart Failure II: Pathophysiology01:29

Heart Failure II: Pathophysiology

144
Systolic Heart Failure and Compensatory MechanismsSystolic heart failure (also termed HFrEF, Heart Failure with Reduced Ejection Fraction) is the most prevalent type of heart filure. It results in a decreased volume of blood being pumped from the ventricle. The aortic arch and carotid sinuses have baroreceptors that detect reduced blood pressure, triggering the sympathetic nervous system (SNS) to release epinephrine and norepinephrine. Initially, this response aims to boost heart rate and...
144
Pharmacokinetics in Geriatric Patients: Effect of Age on Drug Metabolism01:18

Pharmacokinetics in Geriatric Patients: Effect of Age on Drug Metabolism

47
Geriatric patients show significant variation in how their bodies process medications, which can change how effective and safe treatments are. The liver is the primary organ where drug metabolism occurs, involving two main types of chemical reactions: phase I and II. Phase I metabolism is driven by the cytochrome P450 enzyme system, which includes key types such as CYP3A, CYP2D6, and CYP2C9. Research indicates that while aging doesn't notably alter the levels or activity of these enzymes, it...
47
Pathophysiology of Cardiac Performance01:29

Pathophysiology of Cardiac Performance

969
Typical heart performance is influenced by heart rate, rhythm, myocardial contraction, and metabolism or blood flow. The cardiac muscle exhibits distinct electrophysiological features, including pacemaker activity and calcium channel control, which play a vital role in the heart's response to various drugs. The autonomic nervous system, comprising the sympathetic and parasympathetic branches, regulates heart rate. Sympathetic activation increases heart rate, while parasympathetic activation...
969

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Cardiac Lipid Metabolism: Cells, Metabolites, and Rhythms.

Circulation research·2026
Same author

International Utah cardiac recovery symposium (U-CARS) 2025:translational and basic science proceedings.

Heart failure reviews·2026
Same author

Empagliflozin restores cardiac metabolism and suppresses immune activation in acute myocardial infarction.

Atherosclerosis·2025
Same author

Hepato-cardiac interorgan communication controls cardiac hypertrophy via combined endocrine-autocrine FGF21 signaling.

Cell reports. Medicine·2025
Same author

Isolated mouse adult cardiomyocytes display minimal mitochondrial ATP demand and maximal reliance on glycolysis.

Journal of molecular and cellular cardiology·2025
Same author

Corrigendum: Morin inhibits proliferation of SW480 colorectal cancer cells by inducing apoptosis mediated by reactive oxygen species formation and uncoupling of Warburg effect.

Frontiers in pharmacology·2025

Related Experiment Video

Updated: Nov 5, 2025

Improving Strength, Power, Muscle Aerobic Capacity, and Glucose Tolerance through Short-term Progressive Strength Training Among Elderly People
12:59

Improving Strength, Power, Muscle Aerobic Capacity, and Glucose Tolerance through Short-term Progressive Strength Training Among Elderly People

Published on: July 5, 2017

12.8K

Metabolic Complications in Cardiac Aging.

Thomas Sithara1, Konstantinos Drosatos1

  • 1Center for Translational Medicine, Lewis Katz School of Medicine at Temple University, Philadelphia, PA, United States.

Frontiers in Physiology
|May 17, 2021
PubMed
Summary

Aging hearts show altered metabolism, favoring glucose over fatty acids. This shift, combined with mitochondrial dysfunction and oxidative stress, impairs cardiac function in older adults.

Keywords:
autophagycarbohydrate metabolismcardiac agingfatty acid oxidationketone bodiesmitochondria

More Related Videos

Phosphorus-31 Magnetic Resonance Spectroscopy: A Tool for Measuring In Vivo Mitochondrial Oxidative Phosphorylation Capacity in Human Skeletal Muscle
09:40

Phosphorus-31 Magnetic Resonance Spectroscopy: A Tool for Measuring In Vivo Mitochondrial Oxidative Phosphorylation Capacity in Human Skeletal Muscle

Published on: January 19, 2017

11.9K
Analyzing Oxygen Consumption Rate in Primary Cultured Mouse Neonatal Cardiomyocytes Using an Extracellular Flux Analyzer
11:26

Analyzing Oxygen Consumption Rate in Primary Cultured Mouse Neonatal Cardiomyocytes Using an Extracellular Flux Analyzer

Published on: February 13, 2019

8.9K

Related Experiment Videos

Last Updated: Nov 5, 2025

Improving Strength, Power, Muscle Aerobic Capacity, and Glucose Tolerance through Short-term Progressive Strength Training Among Elderly People
12:59

Improving Strength, Power, Muscle Aerobic Capacity, and Glucose Tolerance through Short-term Progressive Strength Training Among Elderly People

Published on: July 5, 2017

12.8K
Phosphorus-31 Magnetic Resonance Spectroscopy: A Tool for Measuring In Vivo Mitochondrial Oxidative Phosphorylation Capacity in Human Skeletal Muscle
09:40

Phosphorus-31 Magnetic Resonance Spectroscopy: A Tool for Measuring In Vivo Mitochondrial Oxidative Phosphorylation Capacity in Human Skeletal Muscle

Published on: January 19, 2017

11.9K
Analyzing Oxygen Consumption Rate in Primary Cultured Mouse Neonatal Cardiomyocytes Using an Extracellular Flux Analyzer
11:26

Analyzing Oxygen Consumption Rate in Primary Cultured Mouse Neonatal Cardiomyocytes Using an Extracellular Flux Analyzer

Published on: February 13, 2019

8.9K

Area of Science:

  • Cardiology
  • Gerontology
  • Metabolic Science

Background:

  • Aging leads to molecular and cellular changes impacting cardiac function.
  • While metabolic disorders are common in the elderly, aging-related cardiomyopathy has distinct characteristics.
  • Cardiac energy production relies on various substrates, with fatty acid oxidation (FAO) being predominant in healthy hearts.

Purpose of the Study:

  • To review the pathophysiology of cardiac aging.
  • To explore alterations in cardiac metabolism during aging.
  • To examine the role of mitochondrial function and systemic metabolic changes in cardiac aging.

Main Methods:

  • Literature review of studies on cardiac aging.
  • Analysis of metabolic shifts in the aging heart.
  • Examination of mitochondrial function and reactive oxygen species (ROS) in cardiac aging.

Main Results:

  • The aging heart shifts substrate utilization from fatty acid oxidation (FAO) to glucose oxidation.
  • Mitochondrial abundance and function are impaired in cardiac aging.
  • Accumulation of reactive oxygen species (ROS) contributes to mitochondrial damage and worsened cardiac function.

Conclusions:

  • Cardiac aging involves significant metabolic reprogramming and mitochondrial dysfunction.
  • Oxidative stress plays a crucial role in the progression of aging-related cardiac decline.
  • Understanding these mechanisms is key to addressing cardiovascular complications in aging populations.